Who Owns OneOncology?

• Parent Company: Cencora Inc.
• Ownership Type: Wholly owned
• Acquisition Year: 2023
• Company Type: Publicly Traded
• Stock Ticker: NYSE: COR

• Founded: 2018
• Founders: OneOncology founding team
• Acquired by Cencora Inc.: 2023

• Founded: 2001
• Headquarters: Conshohocken, Pennsylvania, USA
• Company Type: Publicly Traded
• Stock: NYSE: COR
• Revenue: approximately $293 billion (FY2024, year ended September 2024)
• Employees: Approximately 47,000

Visit Cencora Inc. website

• Headquarters: Nashville, Tennessee, USA
• Manufacturing / Operations: United States

OneOncology operates within Cencora's comprehensive sustainability framework, implementing environmental initiatives and ethical practices as a physician-led community oncology platform. As Cencora's fastest growing platform for independent oncology practices, OneOncology focuses on sustainable healthcare delivery, ethical patient care practices, and responsible business operations that align with Cencora's commitment to environmental stewardship and social responsibility in the healthcare sector.

Sustainable Healthcare Delivery Models: OneOncology promotes sustainable healthcare through practice management solutions that reduce administrative burdens and allow independent oncology practices to focus on patient care rather than administrative tasks. By streamlining operations and improving efficiency, OneOncology helps practices reduce their environmental footprint while maintaining high-quality patient care standards.

Technology-Enabled Environmental Efficiency: OneOncology's digital platforms and technology solutions enable paperless operations, reducing the environmental impact of traditional healthcare documentation and record-keeping. The Oncology Quality Hub and other digital tools facilitate electronic data collection and reporting, eliminating paper waste and supporting sustainable healthcare practices across partner practices.

Ethical Patient Care and Quality Standards: OneOneOne maintains strong ethical standards through its physician-led approach, ensuring that clinical decisions prioritize patient welfare and evidence-based practices. The platform's focus on quality improvement and clinical excellence, demonstrated through CMS QCDR approval and high MIPS scores, reflects its commitment to ethical healthcare delivery and patient outcomes.

Community Health Impact and Accessibility: OneOncology supports community oncology care by making specialized cancer treatment more accessible in local communities. The platform enables independent oncology practices to compete effectively with larger healthcare systems, bringing quality cancer care to underserved areas and reducing patient travel requirements for specialized treatment.

Responsible Supply Chain Management: As part of Cencora's pharmaceutical solutions organization, OneOncology benefits from responsible supply chain practices for medications and healthcare products. The company's focus on secure, reliable delivery of pharmaceuticals supports sustainable healthcare operations while ensuring medication safety and quality standards.

Data Privacy and Security Ethics: OneOncology handles sensitive patient health data with strict privacy and security protocols, maintaining compliance with healthcare regulations including HIPAA and other data protection requirements. The platform's data collection and reporting systems are designed to protect patient confidentiality while enabling quality improvement and research initiatives.

Research and Clinical Trial Support: OneOncology facilitates clinical research participation through its research network transformation into a full-service site management organization, allowing practices to concentrate on clinical aspects while administrative burdens are managed efficiently. This approach supports sustainable medical research and innovation in oncology care.

Professional Development and Education: OneOncology invests in professional development and education for healthcare providers, supporting continuous learning and skill development in oncology care. This investment in human capital contributes to sustainable healthcare workforce development and improved patient care quality over time.

Environmental Compliance in Healthcare Operations: OneOncology maintains compliance with environmental regulations in all operations, ensuring that healthcare facilities and practices meet environmental standards while focusing on patient care delivery and medical waste management.

Long-Term Strategic Sustainability: OneOncology's integration into Cencora's long-term strategy supports sustainable growth in community oncology services, with Cencora raising long-term guidance expectations to reflect OneOncology's expected contribution to enterprise growth and demonstrating commitment to sustainable business development in healthcare.

OneOncology has received significant recognition within the healthcare and oncology industry, particularly for its innovative practice management solutions, quality improvement initiatives, and rapid growth as a platform for independent oncology practices.

CMS QCDR and QR Approval (2024): OneOncology's Oncology Quality Hub achieved approval from the Centers for Medicare & Medicaid Services (CMS) as both a Qualified Clinical Data Registry (QCDR) and a Qualified Registry (QR) in 2024. This recognition demonstrates OneOncology's ability to meet rigorous federal standards for collecting and submitting clinical data as part of CMS's Quality Payment Program, validating the platform's quality reporting capabilities.

ASCO Annual Meeting Research Recognition (2024): OneOncology highlighted groundbreaking research contributions from investigators at partner practices through 13 oral and poster presentations at the 2024 ASCO Annual Meeting. This recognition demonstrates the platform's commitment to advancing oncology research and supporting clinical innovation in community oncology settings.

MIPS Performance Excellence: OneOncology partner practices achieved an average MIPS score of 96 for the 2023 reporting period, marking a 13% improvement year over year. This performance excellence demonstrates the platform's effectiveness in helping practices optimize quality metrics and achieve strong performance in CMS quality payment programs.

Practice Management Innovation Recognition: OneOncology has been acknowledged for transforming its research network into a full-service site management organization, alleviating administrative burdens for participating practices and allowing them to focus on patient-facing clinical care where their expertise is most impactful.

Technology Integration Awards: OneOncology's digital platforms and technology solutions have received recognition for improving practice efficiency and enabling data-driven decision making in oncology care management, particularly for electronic health record integration and quality reporting automation.

Healthcare Quality Leadership: OneOncology's quality improvement programs and clinical support services have been recognized by healthcare quality organizations for driving measurable improvements in patient care quality and practice performance across the independent oncology practice network.

Physician-Led Model Recognition: OneOncology's physician-led approach to community oncology has been acknowledged as an innovative model that balances clinical excellence with business efficiency, supporting independent practice autonomy while providing comprehensive management support services.

Rapid Growth and Market Leadership: As the fastest growing platform for independent oncology practices, OneOncology has received recognition from healthcare industry analysts and business publications for its successful market entry and rapid expansion in the competitive healthcare services market.

Patient Care Excellence Recognition: OneOncology has received positive recognition from healthcare providers and patient advocacy groups for its focus on maintaining high standards of patient care while improving practice efficiency and operational sustainability.

Partnership and Collaboration Excellence: OneOncology's collaborative approach to healthcare partnerships, including its acquisition of Navigating Care and integration of complementary services, has been acknowledged for creating comprehensive solutions for community oncology practices.

Regulatory Compliance Achievement: Oneoncology's ability to navigate complex healthcare regulations and achieve CMS approval for its quality data registry demonstrates excellence in regulatory compliance and healthcare operations management.

OneOncology maintains a strong operational record with no major service recalls or significant controversies that have substantially impacted its reputation or operations in the healthcare services market. However, the platform faces several challenges typical of a rapidly growing healthcare services organization in a complex regulatory environment.

Regulatory Compliance Complexity: OneOncology operates in a highly regulated healthcare environment, facing ongoing challenges related to pharmacy regulations, healthcare compliance requirements, and changing industry standards. The platform must maintain comprehensive compliance programs while adapting to evolving healthcare regulations and quality standards across multiple jurisdictions.

Healthcare Cost Containment Pressures: OneOncology operates in a healthcare environment facing ongoing cost pressures, reimbursement challenges, and budget constraints from long-term care facilities and insurance providers. The platform must balance service quality with cost efficiency while maintaining profitability and growth objectives in a challenging reimbursement landscape.

Integration with Cencora Systems: Following Cencora's majority stake acquisition in 2023 and accelerated acquisition plans in 2025, OneOncology has faced challenges related to integration with larger healthcare systems, standardization of processes, and alignment with corporate strategies while maintaining its physician-led culture and specialized focus.

Technology Adoption Challenges: Oneoncology faces challenges related to technology adoption and digital transformation in healthcare, particularly regarding electronic health records, telehealth services, and automation systems. The platform must balance technology investments with operational efficiency and patient care quality while managing implementation costs and user adoption.

Staffing and Workforce Shortages: OneOncology faces ongoing challenges related to healthcare staffing, workforce shortages, and professional development in the competitive healthcare labor market. The platform must maintain adequate staffing levels while managing labor costs and ensuring consistent service quality across partner practices.

Market Competition and Consolidation Pressure: OneOncology operates in a healthcare industry experiencing significant consolidation and integration, creating both opportunities and challenges for specialized service providers. The company must navigate changing market dynamics while maintaining its specialized focus on community oncology services and independent practice support.

Quality Assurance and Accreditation Maintenance: Oneoncology faces ongoing challenges related to maintaining quality assurance programs and healthcare accreditation standards across all pharmacy operations and partner practices. The platform must continuously improve quality systems while meeting diverse accreditation requirements from healthcare organizations and regulatory bodies.

Supply Chain and Medication Management: Oneoncology faces challenges related to pharmaceutical supply chain management, medication availability, and cost fluctuations in the healthcare industry. The platform must navigate complex supply chain relationships while ensuring consistent medication availability and quality standards across partner practices.

Healthcare Data Privacy and Security: Oneoncology handles sensitive patient health data and must maintain strict compliance with healthcare privacy regulations including HIPAA, ensuring data security and patient confidentiality while enabling quality improvement and research initiatives.

Market Positioning and Brand Recognition Challenges: As a relatively new brand in the healthcare services market, Oneoncology faces challenges related to building brand recognition and establishing trust with healthcare providers and patients in established markets against well-established competitors with longer histories.

Technology Platform Reliability and Performance: Oneoncology's technology platforms must maintain high reliability and performance standards to support critical healthcare operations, requiring continuous investment in technology infrastructure and technical support to ensure consistent service delivery.

Healthcare Policy and Regulatory Changes: Oneoncology must adapt to evolving healthcare policies, regulatory changes, and reimbursement models that impact independent oncology practices, requiring continuous adaptation of business models and service offerings.

Clinical Data Standardization Challenges: Oneoncology faces challenges related to standardizing clinical data collection and reporting across diverse practice settings with different electronic health record systems and clinical workflows, requiring flexible technology solutions and extensive user training and support.

Patient Access and Care Coordination: Oneoncology faces challenges related to ensuring patient access to specialized oncology care and coordinating care across complex healthcare systems, particularly in underserved communities or rural areas with limited specialist oncology resources.

Financial Performance and Profitability Pressures: As a rapidly growing platform, Oneoncology faces pressure to achieve financial performance targets while maintaining service quality and investing in growth initiatives, particularly following Cencora's accelerated acquisition plans and increased investment expectations.

Clinical Research and Innovation Balance: Oneoncology must balance supporting clinical research and innovation opportunities with maintaining focus on core practice management services and ensuring that research activities do not compromise patient care quality or operational efficiency.

Healthcare Industry Reputation and Trust: Oneoncology must build and maintain trust with healthcare providers, patients, and industry stakeholders while navigating the complex healthcare landscape and establishing its position as a reliable partner in community oncology services.